Tag
Japan pharmaceutical sector
COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit
By Hannah Elyse Sworn
The valuable experience gained by Asian companies during the pandemic could upset the West’s monopoly in high-value drugs more generally, with implications for global access to medicines.
Japan’s Struggle for a Home-Grown COVID-19 Vaccine
By Thisanka Siripala
Japan's lagging vaccine roll-out draws attention to the barriers in commercializing domestic vaccine production.
Page 1 of 1